On Jan 29, 2026, SNY reported earnings of 0.74 USD per share (EPS) for Q4 25, missing the estimate of 1.46 USD, resulting in a -49.05% surprise. Revenue reached 11.01 billion, compared to an expected 11.46 billion, with a -3.92% difference. The market reacted with a +0.94% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 4 analysts forecast an EPS of 1.77 USD, with revenue projected to reach 10.52 billion USD, implying an increase of 139.19% EPS, and decrease of -4.47% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Johnson & Johnson
Report Date
Jan 21, 2026 For Q4 25
Estimate
$2.46
Actual
$2.46
Surprise
-0.13%
FAQ
What were Sanofi - ADR's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Sanofi - ADR reported EPS of $0.74, missing estimates by -49.05%, and revenue of $11.01B, -3.92% below expectations.
How did the market react to Sanofi - ADR's Q4 2025 earnings?
The stock price moved up 0.94%, changed from $45.77 before the earnings release to $46.20 the day after.
When is Sanofi - ADR expected to report next?
The next earning report is scheduled for Apr 23, 2026.
What are the forecasts for Sanofi - ADR's next earnings report?
Based on 4
analysts, Sanofi - ADR is expected to report EPS of $1.77 and revenue of $10.52B for Q1 2026.